Diligence memo · auto-generated · as of July 2, 2026
1200 Pharma LLC
1200 Pharma LLC looks under-valued against its niche peers and is quiet on financing cadence.
Businessfiled
1200 Pharma LLC operates in Pharma, based in CULVER CITY.
Sub-sector tags: pharma.
No verified homepage on file yet — operating evidence is limited to the public record.
Capital & rounds (filed)filed
1200 Pharma LLC has raised $14M in disclosed capital across 3 recorded rounds, aggregated from public filings. Its latest round is modeled as Series A (a $4.0M–$15M round).
Largest single filing: $6.2M on 2017-11-15.
Most recent recorded round closed around 2024-04-15.
Valuation (modeled)modeled
Provath models 1200 Pharma LLC at approximately $13M (range $2.7M–$30M). This is an algorithmic estimate from round sizes and same-niche peers — not a quoted or reported figure.
Read: Under-valued. Modeled value is 0.19× the median modeled value of Series A Pharma companies in 2022–2024 (24 peers) — value vs value, same stage and era.
Financing rhythm & timingmixed
Historic cadence: a new round about every 38 months.
Last raise 2.2 yr ago; this sector typically re-raises about every 16 months.
Slightly overdue versus sector cadence.
The last round was 2.4× smaller than the prior — a bridge or down round.
Comparablesmixed
Capital scale ranks ahead of 71% of Pharma peers (310 compared).
Modeled value ranks above 39% of those peers.
Closest niche peers: Carmine Therapeutics, Inc., Triomics, Inc., Spiral Therapeutics Inc, Convelo Therapeutics, Inc., ADvantage Therapeutics, Inc..
Peoplefiled
6 named people on file across officers, directors and signatories.
Risks & flagsmixed
No clearly named CEO/founder/principal in the surfaced records — key-person evidence is thin.